Published in Schizophr Bull on August 27, 2015
From Linkage Studies to Epigenetics: What We Know and What We Need to Know in the Neurobiology of Schizophrenia. Front Neurosci (2016) 0.77
Parsing psychosis subtypes through investigations of rare genetic variants. EBioMedicine (2016) 0.75
Cross-Disorder Psychiatric Genomics. Curr Behav Neurosci Rep (2016) 0.75
Schizophrenia genetics comes to translation. NPJ Schizophr (2017) 0.75
Genetic loci associated with an earlier age at onset in multiplex schizophrenia. Sci Rep (2017) 0.75
PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet (2007) 209.92
An integrated map of genetic variation from 1,092 human genomes. Nature (2012) 59.82
Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature (2009) 33.26
A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet (2009) 30.09
METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics (2010) 21.21
The NCBI dbGaP database of genotypes and phenotypes. Nat Genet (2007) 17.93
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet (2013) 16.76
Biological insights from 108 schizophrenia-associated genetic loci. Nature (2014) 16.13
Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet (2009) 12.96
Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry (2003) 10.44
Genotype imputation with thousands of genomes. G3 (Bethesda) (2011) 8.77
A linear complexity phasing method for thousands of genomes. Nat Methods (2011) 8.30
Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet (2002) 7.40
The dopamine hypothesis of schizophrenia: version III--the final common pathway. Schizophr Bull (2009) 6.03
The future of association studies: gene-based analysis and replication. Am J Hum Genet (2004) 5.44
Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry (1991) 5.36
GATES: a rapid and powerful gene-based association test using extended Simes procedure. Am J Hum Genet (2011) 3.34
Toward new approaches to psychotic disorders: the NIMH Research Domain Criteria project. Schizophr Bull (2010) 3.21
A separate disease within the syndrome of schizophrenia. Arch Gen Psychiatry (2001) 3.10
A comprehensive family-based replication study of schizophrenia genes. JAMA Psychiatry (2013) 2.93
ConsensusPathDB: toward a more complete picture of cell biology. Nucleic Acids Res (2010) 2.79
The deacetylase HDAC6 is a novel critical component of stress granules involved in the stress response. Genes Dev (2007) 2.43
Mutations in the alpha 1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia. Nat Genet (1993) 2.35
Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia. Am J Psychiatry (2005) 2.29
Neuregulin and ErbB receptor signaling pathways in the nervous system. Curr Opin Neurobiol (2001) 2.20
Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Mol Psychiatry (2012) 2.07
Genome-wide association study implicates HLA-C*01:02 as a risk factor at the major histocompatibility complex locus in schizophrenia. Biol Psychiatry (2012) 1.74
Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents. Mol Psychiatry (2012) 1.73
Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia. Mol Psychiatry (2003) 1.73
Genetic heterogeneity, modifier genes, and quantitative phenotypes in psychiatric illness: searching for a framework. Mol Psychiatry (2005) 1.58
Association of the NRG1 gene and schizophrenia: a meta-analysis. Mol Psychiatry (2006) 1.48
How many and which are the psychopathological dimensions in schizophrenia? Issues influencing their ascertainment. Schizophr Res (2001) 1.44
HYST: a hybrid set-based test for genome-wide association studies, with application to protein-protein interaction-based association analysis. Am J Hum Genet (2012) 1.41
Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia. Mol Psychiatry (2013) 1.39
Autoimmune diseases and infections as risk factors for schizophrenia. Ann N Y Acad Sci (2012) 1.37
What we know: findings that every theory of schizophrenia should explain. Schizophr Bull (2009) 1.27
DIST: direct imputation of summary statistics for unmeasured SNPs. Bioinformatics (2013) 1.25
Genome-wide association study of the rate of cognitive decline in Alzheimer's disease. Alzheimers Dement (2013) 1.25
Dysbindin genotype and negative symptoms in schizophrenia. Am J Psychiatry (2006) 1.17
Genome-wide association study of clinical dimensions of schizophrenia: polygenic effect on disorganized symptoms. Am J Psychiatry (2012) 1.15
Novel linkage to chromosome 20p using latent classes of psychotic illness in 270 Irish high-density families. Biol Psychiatry (2008) 1.13
A genome-wide association study of neuroticism in a population-based sample. PLoS One (2010) 1.09
No evidence for linkage or association of neuregulin-1 (NRG1) with disease in the Irish study of high-density schizophrenia families (ISHDSF). Mol Psychiatry (2004) 1.08
Tudor-SN interacts with and co-localizes with G3BP in stress granules under stress conditions. FEBS Lett (2010) 1.03
Familiality of novel factorial dimensions of schizophrenia. Arch Gen Psychiatry (2009) 1.02
Genome scan of three quantitative traits in schizophrenia pedigrees. Biol Psychiatry (2002) 1.00
Scapinin, the protein phosphatase 1 binding protein, enhances cell spreading and motility by interacting with the actin cytoskeleton. PLoS One (2009) 0.95
Neuregulin 1 genotype and schizophrenia. Schizophr Bull (2007) 0.95
Distribution of the branched chain aminotransferase proteins in the human brain and their role in glutamate regulation. J Neurochem (2012) 0.93
Genetic and radiation hybrid mapping of the hyperekplexia region on chromosome 5q. Am J Hum Genet (1992) 0.93
Clinical symptomatology and the psychosis risk gene ZNF804A. Schizophr Res (2010) 0.91
No association between catechol-o-methyltransferase Val108/158Met polymorphism and schizophrenia or its clinical symptomatology in a Mexican population. Mol Biol Rep (2012) 0.89
A genome-wide scan for modifier loci in schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2007) 0.89
COMT genotype and manic symptoms in schizophrenia. Schizophr Res (2006) 0.89
BDNF val66met polymorphism is associated with age at onset and intensity of symptoms of paranoid schizophrenia in a Polish population. J Neuropsychiatry Clin Neurosci (2013) 0.88
Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings. Psychiatry Clin Neurosci (2013) 0.87
Molecular validation of the schizophrenia spectrum. Schizophr Bull (2013) 0.87
Mitochondrial DNA deletion mutations in patients with neuropsychiatric symptoms. Neurosci Res (2010) 0.86
Concordance between chart review and structured interview assessments of schizophrenic symptoms. Compr Psychiatry (2011) 0.86
Association study of neuregulin-1 gene polymorphisms in a North Indian schizophrenia sample. Schizophr Res (2013) 0.86
Scapinin-induced inhibition of axon elongation is attenuated by phosphorylation and translocation to the cytoplasm. J Biol Chem (2011) 0.86
Association study of SNAP25 and schizophrenia in Irish family and case-control samples. Am J Med Genet B Neuropsychiatr Genet (2010) 0.81
Pharmacoproteomic investigation into antidepressant response in two mouse inbred strains. Proteomics (2012) 0.80
No association of dysbindin with symptom factors of schizophrenia in an Irish case-control sample. Am J Med Genet B Neuropsychiatr Genet (2010) 0.79
Expression pattern of sorting Nexin 25 in temporal lobe epilepsy: a study on patients and pilocarpine-induced rats. Brain Res (2013) 0.78
Comprehensive gene-based association study of a chromosome 20 linked region implicates novel risk loci for depressive symptoms in psychotic illness. PLoS One (2011) 0.77